Common TRT Side Effects: What to Expect and How to Manage Each One

Key Takeaways

• Most TRT side effects are dose-dependent and manageable with proper monitoring
• Elevated hematocrit (thickened blood) is the most common clinically significant side effect, occurring in roughly 5-20% of patients depending on dose and delivery method
• Acne, oily skin, and hair shedding are common in the first 3-6 months and often stabilize
• Testicular shrinkage is nearly universal on TRT but is reversible with hCG co-therapy for those wanting to preserve fertility
• Sleep apnea can worsen with TRT in predisposed individuals — screening before starting is important
• Regular lab monitoring (every 3-6 months) is the best defense against serious side effects

Side effects get a lot of attention when people search for TRT — sometimes more than the benefits. That's understandable. If you're considering testosterone therapy, you want to know exactly what might change in your body, how likely each change is, and whether you'll be able to do anything about it.

The clinical literature on TRT side effects is deep and spans decades of randomized controlled trials, observational studies, and meta-analyses. The Endocrine Society's clinical practice guidelines, the Testosterone Trials (TTrials), and more recent real-world cohort studies all provide a clear picture: TRT is generally safe when properly monitored, but it does produce predictable hormonal shifts that can cause side effects in some men.

This guide breaks down each side effect, how often it occurs, why it happens, and what strategies clinicians use to manage it. It is educational content based on published research and clinical guidelines — not a substitute for medical advice from your own physician.

How Dose and Delivery Method Affect Side Effect Risk

Almost every TRT side effect is dose-dependent. Higher doses, supraphysiological levels, and wide peaks and troughs in blood testosterone levels all increase the likelihood and severity of side effects. That's why modern TRT protocols emphasize the lowest effective dose that resolves symptoms while keeping lab values in the therapeutic range.

Delivery method also matters. Intramuscular injections tend to produce higher peak levels and wider fluctuations than transdermal gels or subcutaneous micro-dosing. Many patients who experience side effects on a traditional weekly injection protocol find that splitting the dose into twice-weekly or even every-other-day subcutaneous injections significantly reduces or eliminates them. This is because smaller, more frequent doses produce a steadier blood concentration with fewer peaks.

Transdermal gels and patches produce the most stable levels but come with their own considerations, including skin irritation at the application site and transfer risk to others through skin contact.

Elevated Hematocrit (Erythrocytosis)

How common:

Estimated to occur in 5-20% of TRT patients, with higher rates in those receiving higher doses, intramuscular injections, and those with baseline high-normal hematocrit. A 2020 meta-analysis in The Lancet Diabetes & Endocrinology found that erythrocytosis was the most frequently reported adverse event in TRT trials.

What it is:

Testosterone stimulates red blood cell production through several mechanisms, including direct effects on bone marrow and increased erythropoietin. When the percentage of red blood cells in your blood (hematocrit) rises too high, blood becomes thicker and more viscous, which can increase the risk of blood clots, stroke, and cardiovascular events.

Management strategies:

• Regular monitoring: Hematocrit should be checked at baseline, 3-6 months after starting TRT, and annually thereafter (more frequently if elevated)
• Dose reduction: If hematocrit exceeds 54%, most guidelines recommend reducing the TRT dose or temporarily discontinuing therapy
• Delivery method change: Switching from intramuscular injections to transdermal gel can reduce erythrocytosis risk
• Therapeutic phlebotomy: In some cases, physicians recommend periodic blood donation or therapeutic phlebotomy to lower hematocrit
• Hydration: Adequate hydration can help, though it doesn't address the underlying mechanism

The Endocrine Society recommends holding TRT if hematocrit exceeds 54% and resuming only at a lower dose once levels normalize. This is one of the most important monitoring parameters during TRT.

Acne and Oily Skin

How common:

Reported in approximately 5-10% of TRT users. More common in those with a personal history of acne or those starting TRT at younger ages.

What it is:

Testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5-alpha reductase. DHT increases sebum production in the skin's sebaceous glands, which can clog pores and lead to acne. Oily skin often precedes acne and is itself a noticeable change.

Management strategies:

• Dose adjustment: Lowering the dose often reduces acne severity
• Topical treatments: Over-the-counter retinoids, benzoyl peroxide, or salicylic acid can manage mild to moderate acne
• Prescription options: A physician may prescribe topical or oral antibiotics, or isotretinoin (Accutane) for severe cases
• 5-alpha reductase inhibitors: Finasteride can reduce DHT levels but may have its own side effects profile — this should only be considered under physician guidance

Many patients find that acne peaks in the first 2-3 months of TRT and then improves as the body adjusts to the new hormone levels.

Hair Loss (Androgenic Alopecia)

How common:

Rates vary widely and are difficult to separate from age-related hair loss patterns. Men with a genetic predisposition to male pattern baldness (androgenic alopecia) may experience accelerated hair loss on TRT.

What it is:

Like acne, TRT-related hair loss is driven by DHT. Testosterone converts to DHT, which binds to androgen receptors in hair follicles on the scalp, gradually miniaturizing them and shortening the growth phase of the hair cycle. This process primarily affects genetically susceptible men.

Management strategies:

• Topical minoxidil: FDA-approved, available over the counter, can slow hair loss and promote regrowth in some men
• Finasteride or dutasteride: 5-alpha reductase inhibitors that reduce DHT by 60-90%. These can be effective for hair preservation but come with their own side effect considerations that must be weighed carefully
• Low-level laser therapy: Some evidence supports the use of laser caps or combs as adjunctive treatment
• Acceptance and dose management: For some men, the benefits of TRT outweigh hair loss concerns. Keeping testosterone in the mid-normal range rather than pushing to the high end may reduce the impact

It's important to note that men without a genetic predisposition to male pattern baldness typically do not experience significant hair loss from TRT alone. TRT doesn't create new hair loss — it can accelerate what genetics were already going to do.

Testicular Atrophy (Shrinkage)

How common:

Universal with TRT when no fertility-preserving adjunct is used. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which shuts down the signal (luteinizing hormone, or LH) that tells the testes to produce testosterone and maintain their size.

What it is:

The testes shrink because they are no longer actively producing testosterone or sperm — the Leydig cells go dormant without LH stimulation. This is a physical manifestation of the suppressed HPG axis, not tissue damage. The testes typically regain size and function after TRT is discontinued, though the timeline and degree of recovery varies.

Management strategies:

• hCG co-therapy: Human chorionic gonadotropin mimics LH and can preserve testicular function and size during TRT. Typically dosed at 250-500 IU 2-3 times per week alongside TRT
• Clomiphene/enclomiphene: For men who want to maintain their own testosterone production, SERMs like clomiphene or enclomiphene may be alternatives to TRT that preserve fertility and testicular function
• Expectation setting: For men who are not concerned about fertility, the shrinkage is cosmetic in nature. The testes typically reduce to a smaller but healthy state

Mood and Behavioral Changes

How common:

Mood effects are highly individual. Some men report improved mood and well-being, while others experience irritability, increased anxiety, or mood swings, especially during the initial adjustment period or with poorly calibrated dosing.

What happens:

Testosterone affects neurotransmitter systems including serotonin, dopamine, and GABA. Changes in testosterone levels can influence mood, aggression, libido, and energy. The direction of these changes depends on baseline levels, the degree of increase, individual sensitivity, and whether levels are stable or fluctuating.

Management strategies:

• Stable dosing: Frequent, smaller doses produce steadier levels and fewer mood swings than large, infrequent doses
• Time: Most men report mood stabilization within 4-8 weeks of starting TRT as the body adjusts
• Mental health support: Men with a history of mood disorders should be closely monitored. Some may need concurrent mental health support
• Dose review: If irritability, agitation, or significant mood changes persist beyond the initial adjustment period, the dose should be re-evaluated by a physician

The Testosterone Trials found that TRT improved mood and depressive symptoms in men aged 65 and older with clearly low testosterone, but individual responses varied.

Sleep Apnea

How common:

TRT's relationship with sleep apnea is complex. The risk is highest in men who already have untreated or borderline obstructive sleep apnea. Studies have reported mixed results, but current guidance suggests screening for sleep apnea before starting TRT.

What happens:

Testosterone may affect the neuromuscular control of the upper airway, potentially worsening existing obstructive sleep apnea. The exact mechanism is not fully understood. Some early studies suggested TRT could cause new-onset sleep apnea, but more recent research suggests it primarily worsens pre-existing, undiagnosed cases rather than creating new ones.

Management strategies:

• Pre-treatment screening: Men with symptoms of sleep apnea (loud snoring, daytime sleepiness, witnessed apneas) should be screened before starting TRT
• CPAP therapy: For men with diagnosed sleep apnea, proper treatment with CPAP should be established before starting TRT
• Ongoing monitoring: New or worsening sleep symptoms during TRT should be reported to a physician promptly

Gynecomastia (Breast Tissue Enlargement)

How common:

Uncommon (~1-5%) but can occur. Risk is higher at supratherapeutic doses where excess testosterone is converted to estrogen via aromatase.

What it is:

Gynecomastia occurs when some of the circulating testosterone is converted to estradiol (estrogen) by the aromatase enzyme. If estrogen levels rise disproportionately, it can stimulate breast tissue growth. This typically happens when TRT doses are too high, pushing testosterone and consequently estrogen above physiological ranges.

Management strategies:

• Dose reduction: Bringing testosterone into the mid-normal range usually resolves this
• Aromatase inhibitors: In some cases, physicians prescribe anastrozole or letrozole to manage elevated estrogen. However, routine use of aromatase inhibitors is controversial and should only be done under physician guidance (see our separate article on aromatase inhibitor use during TRT)
• Time: Mild, early gynecomastia may resolve with dose adjustment before tissue becomes fibrous and permanent

Gynecomastia that persists for several months without intervention can become fibrotic and may require surgical correction, which is why early monitoring and dose adjustment are important.

Skin Changes Beyond Acne

What to expect:

• Oily skin: Increased sebum production is common, especially in the first few months
• Increased body hair: Some men notice increased facial or body hair growth
• Skin sensitivity: Application site reactions are common with transdermal gels (redness, itching) and can usually be managed by rotating application sites or switching delivery methods
• Injection site reactions: Localized redness, swelling, or nodules can occur with intramuscular or subcutaneous injections, typically resolving within a few days

Management:

Most skin changes are mild and manageable. Rotating injection sites, using proper injection technique, and maintaining good skincare routines address most issues. For persistent transdermal reactions, switching to injections or an alternative gel formulation may help.

Prostate Changes

What the research says:

TRT does not appear to cause prostate cancer, according to large meta-analyses including data from the Journal of the American Medical Association (JAMA). However, it can stimulate growth of existing prostate tissue, leading to increases in prostate-specific antigen (PSA) levels.

Management strategies:

• Baseline PSA testing: Men should have PSA measured before starting TRT to rule out existing prostate concerns
• Regular monitoring: PSA should be rechecked at 3-6 months and annually. A rise of more than 1.4 ng/mL within the first year warrants urology referral
• Benign prostatic hyperplasia (BPH): TRT can worsen urinary symptoms in men with existing BPH. Symptoms should be monitored and managed accordingly

Current evidence from the Prostate Cancer Trials and other large studies has not demonstrated an increased prostate cancer risk with properly monitored TRT in hypogonadal men, but ongoing surveillance remains standard practice.

Fertility and Sperm Count

What happens:

TRT suppresses sperm production (spermatogenesis) by suppressing the HPG axis. This is well-documented and is the reason TRT is sometimes (misguidedly) used as a form of male contraception. Studies show that sperm counts can drop to zero (azoospermia) within 3-6 months of starting TRT.

Management strategies:

• Fertility preservation: Men who want future fertility should bank sperm before starting TRT
• hCG co-therapy: Preserves testicular function and sperm production during TRT
• Alternative therapies: SERMs (clomiphene, enclomiphene) or hCG monotherapy can raise endogenous testosterone without suppressing fertility

See our detailed article on TRT and fertility for a full discussion of how TRT affects sperm count and what options exist.

Fluid Retention and Edema

How common:

Mild fluid retention occurs in a minority of TRT patients, typically in the first few weeks of treatment.

What it is:

Testosterone can cause sodium and water retention, leading to mild swelling in the ankles, feet, or hands. This is usually transient and resolves as the body adjusts.

Management:

• Time: Most fluid retention resolves within 2-4 weeks
• Dose reduction: If excessive, lowering the dose can help
• Sodium management: Reducing dietary sodium intake may help reduce the degree of fluid retention
• Medical evaluation: Significant or persistent edema should be evaluated for cardiac or renal causes

When to Contact Your Doctor

Regardless of which side effects you experience, certain signs warrant prompt medical attention:

• Shortness of breath or chest pain
• Sudden onset of severe headache or vision changes
• Painful urination, blood in urine, or significant urinary changes
• Unusual breast lumps or nipple discharge
• Severe mood changes, agitation, or depression
• Severe injection site reactions (widespread redness, warmth, pus)
• A yellowing of the skin or eyes (jaundice), which can indicate liver stress

These are not exhaustive and do not constitute diagnostic guidance. If you experience symptoms that concern you, contact your healthcare provider. This content is based on published research and clinical guidelines and is intended for educational purposes.

Bottom Line

TRT side effects are real, but most are manageable, predictable, and dose-dependent. The single most important thing you can do to minimize side effects is work with a qualified clinician who monitors your labs regularly and adjusts your dose based on actual blood levels, not guesswork.

The men who report the worst experiences with TRT side effects typically fall into two categories: those who self-treat without medical supervision and lab monitoring, and those who are started on excessively high doses. With proper dosing, regular blood work, and open communication with your doctor, the vast majority of side effects can be prevented or effectively managed.

Regular lab monitoring — including hematocrit, PSA, lipid panel, and comprehensive hormone panels — should be the standard of care for anyone on TRT. If your provider isn't running these labs at least annually, consider finding one who does.